Argus lowered the firm’s price target on Integer (ITGR) to $152 from $160 and keeps a Buy rating on the shares. The firm cites the company’s ...

Argus Research analyst Steven Silver maintained a Buy rating on Integer Holdings (ITGR – Research Report) yesterday. The company’s shares ...

Full Year 2024 Results Key Financial Results Revenue: US$1.72b (up 7.5% from FY ...

Medical technology company Integer Holdings (NYSE:ITGR) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up ...

Principal Financial Group Inc. lifted its stake in shares of Integer Holdings Co. (NYSE:ITGR – Free Report) by 3.9% in the ...

Integer Holdings Corporation ITGR delivered adjusted earnings per share (EPS) of $1.43 in the fourth quarter of 2024, which ...

Medical technology company Integer Holdings (NYSE:ITGR) will be announcing earnings results tomorrow before market hours.

Integer Holdings Corporation (NYSE: ITGR), a prominent manufacturer of medical devices, announced its financial performance for the fourth quarter and the full year that ended on December 31, 2024, on ...

Learn more about whether Integer Holdings Corporation or NovoCure Limited is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The Plano, Texas-based company said it had profit of 90 cents per share. Earnings, adjusted for amortization costs and non-recurring costs, came to $1.43 per share. The results missed Wall Street ...